世界の気管支拡張薬市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV03494)
◆英語タイトル:Global Bronchodilators Market Insights and Forecast to 2026
◆商品コード:QYR20NV03494
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:112
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは気管支拡張薬の世界市場について調査・分析した資料です。種類別(抗コリン作用性気管支拡張薬、アドレナリン作動性気管支拡張薬、気管支拡張薬配合剤、メチルキサンチン)の市場規模、用途別(喘息、COPD、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別気管支拡張薬の競争状況、市場シェア
・世界の気管支拡張薬市場:種類別市場規模 2015年-2020年(抗コリン作用性気管支拡張薬、アドレナリン作動性気管支拡張薬、気管支拡張薬配合剤、メチルキサンチン)
・世界の気管支拡張薬市場:種類別市場規模予測 2021年-2026年(抗コリン作用性気管支拡張薬、アドレナリン作動性気管支拡張薬、気管支拡張薬配合剤、メチルキサンチン)
・世界の気管支拡張薬市場:用途別市場規模 2015年-2020年(喘息、COPD、その他)
・世界の気管支拡張薬市場:用途別市場規模予測 2021年-2026年(喘息、COPD、その他)
・北米の気管支拡張薬市場分析:米国、カナダ
・ヨーロッパの気管支拡張薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの気管支拡張薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の気管支拡張薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの気管支拡張薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):AstraZeneca、Boehringer Ingelheim、GlaxoSmithKline、F. Hoffmann-La Roche
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or requires prescription. Basically there are available in three forms injectable, oral and inhaled. In oral forms they come in variety such as liquids, tablets and capsules, these oral forms are delivered in higher doses which is directly absorbed into the bloodstream and so they have relatively more side effects. Whereas inhaled once are directly deposited in the lungs causing less side effects. Bronchodilators are of basically-acting or long-acting beta2-agonists and anticholinergic agents or theophylline. They function so as to control asthma and COPD. Short acting bronchodilators function for fast relief of asthma symptoms and long acting bronchodilators function for control symptoms of asthma.
Increase in prevalence of pulmonary disorders, smoking, and junk food fuel the bronchodilators market growth. In addition, rise in disposable income, geriatric population, and increase in awareness of healthcare among population are anticipated to boost the market growth. However, side effects associated with bronchodilators and government regulations related to the safety & efficacy of the bronchodilators hinder the market. Ongoing R&D activities related to bronchodilators are anticipated to present new opportunities for the market.

Market Analysis and Insights: Global Bronchodilators Market
The global Bronchodilators market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Bronchodilators Scope and Market Size
Bronchodilators market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bronchodilators market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Bronchodilators market is segmented into
Anticholinergic Bronchodilators
Adrenergic Bronchodilators
Bronchodilator Combinations
Methylxanthines

Segment by Application, the Bronchodilators market is segmented into
Asthma
COPD
Others

Regional and Country-level Analysis
The Bronchodilators market is analysed and market size information is provided by regions (countries).
The key regions covered in the Bronchodilators market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bronchodilators Market Share Analysis
Bronchodilators market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bronchodilators business, the date to enter into the Bronchodilators market, Bronchodilators product introduction, recent developments, etc.

The major vendors covered:
AstraZeneca
Boehringer Ingelheim
GlaxoSmithKline
F. Hoffmann-La Roche

【レポートの目次】

1 Study Coverage
1.1 Bronchodilators Product Introduction
1.2 Market Segments
1.3 Key Bronchodilators Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bronchodilators Market Size Growth Rate by Type
1.4.2 Anticholinergic Bronchodilators
1.4.3 Adrenergic Bronchodilators
1.4.4 Bronchodilator Combinations
1.4.5 Methylxanthines
1.5 Market by Application
1.5.1 Global Bronchodilators Market Size Growth Rate by Application
1.5.2 Asthma
1.5.3 COPD
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Bronchodilators Market Size, Estimates and Forecasts
2.1.1 Global Bronchodilators Revenue 2015-2026
2.1.2 Global Bronchodilators Sales 2015-2026
2.2 Global Bronchodilators, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Bronchodilators Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Bronchodilators Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Bronchodilators Competitor Landscape by Players
3.1 Bronchodilators Sales by Manufacturers
3.1.1 Bronchodilators Sales by Manufacturers (2015-2020)
3.1.2 Bronchodilators Sales Market Share by Manufacturers (2015-2020)
3.2 Bronchodilators Revenue by Manufacturers
3.2.1 Bronchodilators Revenue by Manufacturers (2015-2020)
3.2.2 Bronchodilators Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bronchodilators Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bronchodilators Revenue in 2019
3.2.5 Global Bronchodilators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Bronchodilators Price by Manufacturers
3.4 Bronchodilators Manufacturing Base Distribution, Product Types
3.4.1 Bronchodilators Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bronchodilators Product Type
3.4.3 Date of International Manufacturers Enter into Bronchodilators Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Bronchodilators Market Size by Type (2015-2020)
4.1.1 Global Bronchodilators Sales by Type (2015-2020)
4.1.2 Global Bronchodilators Revenue by Type (2015-2020)
4.1.3 Bronchodilators Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bronchodilators Market Size Forecast by Type (2021-2026)
4.2.1 Global Bronchodilators Sales Forecast by Type (2021-2026)
4.2.2 Global Bronchodilators Revenue Forecast by Type (2021-2026)
4.2.3 Bronchodilators Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bronchodilators Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Bronchodilators Market Size by Application (2015-2020)
5.1.1 Global Bronchodilators Sales by Application (2015-2020)
5.1.2 Global Bronchodilators Revenue by Application (2015-2020)
5.1.3 Bronchodilators Price by Application (2015-2020)
5.2 Bronchodilators Market Size Forecast by Application (2021-2026)
5.2.1 Global Bronchodilators Sales Forecast by Application (2021-2026)
5.2.2 Global Bronchodilators Revenue Forecast by Application (2021-2026)
5.2.3 Global Bronchodilators Price Forecast by Application (2021-2026)

6 North America
6.1 North America Bronchodilators by Country
6.1.1 North America Bronchodilators Sales by Country
6.1.2 North America Bronchodilators Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Bronchodilators Market Facts & Figures by Type
6.3 North America Bronchodilators Market Facts & Figures by Application

7 Europe
7.1 Europe Bronchodilators by Country
7.1.1 Europe Bronchodilators Sales by Country
7.1.2 Europe Bronchodilators Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bronchodilators Market Facts & Figures by Type
7.3 Europe Bronchodilators Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Bronchodilators by Region
8.1.1 Asia Pacific Bronchodilators Sales by Region
8.1.2 Asia Pacific Bronchodilators Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Bronchodilators Market Facts & Figures by Type
8.3 Asia Pacific Bronchodilators Market Facts & Figures by Application

9 Latin America
9.1 Latin America Bronchodilators by Country
9.1.1 Latin America Bronchodilators Sales by Country
9.1.2 Latin America Bronchodilators Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Bronchodilators Market Facts & Figures by Type
9.3 Central & South America Bronchodilators Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Bronchodilators by Country
10.1.1 Middle East and Africa Bronchodilators Sales by Country
10.1.2 Middle East and Africa Bronchodilators Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Bronchodilators Market Facts & Figures by Type
10.3 Middle East and Africa Bronchodilators Market Facts & Figures by Application

11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Bronchodilators Products Offered
11.1.5 AstraZeneca Related Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Corporation Information
11.2.2 Boehringer Ingelheim Description and Business Overview
11.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Boehringer Ingelheim Bronchodilators Products Offered
11.2.5 Boehringer Ingelheim Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Bronchodilators Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Corporation Information
11.4.2 F. Hoffmann-La Roche Description and Business Overview
11.4.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.4.4 F. Hoffmann-La Roche Bronchodilators Products Offered
11.4.5 F. Hoffmann-La Roche Related Developments
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Bronchodilators Products Offered
11.1.5 AstraZeneca Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Bronchodilators Market Estimates and Projections by Region
12.1.1 Global Bronchodilators Sales Forecast by Regions 2021-2026
12.1.2 Global Bronchodilators Revenue Forecast by Regions 2021-2026
12.2 North America Bronchodilators Market Size Forecast (2021-2026)
12.2.1 North America: Bronchodilators Sales Forecast (2021-2026)
12.2.2 North America: Bronchodilators Revenue Forecast (2021-2026)
12.2.3 North America: Bronchodilators Market Size Forecast by Country (2021-2026)
12.3 Europe Bronchodilators Market Size Forecast (2021-2026)
12.3.1 Europe: Bronchodilators Sales Forecast (2021-2026)
12.3.2 Europe: Bronchodilators Revenue Forecast (2021-2026)
12.3.3 Europe: Bronchodilators Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Bronchodilators Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Bronchodilators Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Bronchodilators Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Bronchodilators Market Size Forecast by Region (2021-2026)
12.5 Latin America Bronchodilators Market Size Forecast (2021-2026)
12.5.1 Latin America: Bronchodilators Sales Forecast (2021-2026)
12.5.2 Latin America: Bronchodilators Revenue Forecast (2021-2026)
12.5.3 Latin America: Bronchodilators Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Bronchodilators Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Bronchodilators Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Bronchodilators Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Bronchodilators Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Bronchodilators Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bronchodilators Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

AstraZeneca、Boehringer Ingelheim、GlaxoSmithKline、F. Hoffmann-La Roche

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の気管支拡張薬市場2026:インサイト・予測(Global Bronchodilators Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。